Abstract:Aim: To gain greater knowledge regarding the natural history of aromatic L-amino acid decarboxylase (AADC) deficiency, a genetic disorder that causes severe deficits in motor and cognitive development. Materials & methods: A systematic literature review was performed of all case reports and clinical studies published through December 2019 of patients with AADC deficiency. The data were summarized descriptively. Results: The search identified 94 publications that described 237 unique patients. Mean (standard deviation) age at diagnosis was 3.2 (±5.7) years and 16 deaths were reported. Most patients (57%) received the standard of care therapies, which showed limited efficacy in this patient population. Conclusion: AADC deficiency is a devastating disease and prospectively defined natural history studies are warranted to further understand this disease. The article describes an analysis of the published medical literature that summarized the characteristics of patients with aromatic L-amino acid decarboxylase (AADC) deficiency. AADC deficiency is a very rare genetic disorder that results in loss of AADC enzyme activity and consequently the lack of the neurotransmitters dopamine and serotonin resulting in patients having severe loss of muscle and cognitive function. Data from publications were used to evaluate the frequency of specific symptoms of the disease, muscle function, underlying genotypes and therapies used to treat AADC deficiency. The results show that AADC deficiency is present worldwide and is due to a variety of underlying genetic mutations in the gene that produces the AADC protein. Diagnosis of the disease is often delayed and does not usually occur until about 3 years of age. Often, these patients die within the first decade of life. The standard treatment of AADC, which does not involve gene therapy, is limited in its ability to treat the symptoms of the disease with only about 3% of patients, who at most have head control by 2 years of age, improving following treatment. This study clearly indicates that AADC deficiency is a devastating disease in which standard therapy is not effective and highlights the need for new therapies, including gene therapies, that treat the primary cause of the disease.

Consensus guideline for the diagnosis and treatment of aromatic l-amino acid decarboxylase (AADC) deficiency

Aromatic L-amino Acid Decarboxylase (AADC) deficiency: results from an Italian modified Delphi consensus

Aromatic L-amino acid decarboxylase deficiency: a systematic review

Clinical Features in Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency: A Systematic Review

Mild/moderate phenotypes in AADC deficiency: Focus on the aromatic amino acid decarboxylase protein

Optimizing the anesthetic care of patients with aromatic l-amino acid decarboxylase deficiency

Gene therapy for aromatic L‐amino acid decarboxylase deficiency: requirements for safe application and knowledge‐generating follow‐up

Symptoms and impact of aromatic l-amino acid decarboxylase (AADC) deficiency: a qualitative study and the development of a patient-centred conceptual model

Aromatic L-Amino Acid Decarboxylase Deficiency Diagnosed by Clinical Metabolomic Profiling of Plasma

A position statement on the post gene-therapy rehabilitation of aromatic I-amino acid decarboxylase deficiency patients

Aromatic L-Amino Acid Decarboxylase Deficiency: A Genetic Screening in Sicilian Patients with Neurological Disorders

Report of Two Never Treated Adult Sisters with Aromatic l-Amino Acid Decarboxylase Deficiency: A Portrait of the Natural History of the Disease or an Expanding Phenotype?

Evaluation and Management of Deficiency of Adenosine Deaminase 2: an International Consensus Statement.

Atypical Presentation of Aromatic L-Amino Acid Decarboxylase Deficiency with Developmental Epileptic Encephalopathy

Carrier frequency and incidence of aromatic L-amino acid decarboxylase deficiency: a gnomAD-based study

An attenuated, adult case of AADC deficiency demonstrated by protein characterization

Succinic semialdehyde dehydrogenase deficiency: review of the clinical phenotype and metabolic/genomic approach to diagnosis

Gene therapy for aromatic L-amino acid decarboxylase deficiency by MR-guided direct delivery of AAV2-AADC to midbrain dopaminergic neurons

Clinical Metabolomics to Segregate Aromatic Amino Acid Decarboxylase Deficiency from Drug-Induced Metabolite Elevations

Oculogyric crisis mimicked epilepsy in a Chinese aromatic L-amino acid decarboxylase-deficiency patient: A case report

Case report: Childhood epilepsy and borderline intellectual functioning hiding an AADC deficiency disorder associated with compound heterozygous DDC gene pathogenic variants